Premium
Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization
Author(s) -
Kurup Shree,
Lew Julie,
Byrnes Gordon,
Yeh Steven,
Nussenblatt Robert,
LevyClarke Grace
Publication year - 2009
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2008.01208.x
Subject(s) - bevacizumab , medicine , ophthalmology , uveitis , choroidal neovascularization , neovascularization , macular degeneration , surgery , chemotherapy , angiogenesis
. Purpose: To evaluate the therapeutic effect of intravitreal bevacizumab in patients with uveitis‐associated choroidal/retinal neovascularization. Methods: Two female patients (40 years, 15 years) with posterior uveitis, (one presumed ocular sarcoidosis, one lupus) were evaluated for neovascularization of the posterior segment. Both patients were given a single dose of 1.25 mg intravitreal bevacizumab. Results: Significant anatomical and functional recovery was evident in both patients within a few weeks. Conclusion: In selected uveitic patients, bevacizumab may be an option for managing neovascularization.